Found: 43
Select item for more details and to access through your institution.
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1592, doi. 10.1093/brain/awac333
- By:
- Publication type:
- Article
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Preliminary performance of the Lumipulse G pTau 217 Plasma prototype assay on plasma samples.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079647
- By:
- Publication type:
- Article
CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3379, doi. 10.1002/alz.12919
- By:
- Publication type:
- Article
Analytical performance of the Lumipulse<sup>®</sup> G β‐Amyloid 1‐40 Plasma and Lumipulse<sup>®</sup> G β‐Amyloid 1‐42 Plasma RUO assays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068990
- By:
- Publication type:
- Article
Analytical performance overview of the Lumipulse G pTau 181 Plasma RUO.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064041
- By:
- Publication type:
- Article
Diagnostic and Prognostic Performance of the Modified Lumipulse pTau 181 Assay in Plasma for Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.060879
- By:
- Publication type:
- Article
Reducing misdiagnosis of Alzheimer's Disease pathology utilizing CSF and amyloid PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.066569
- By:
- Publication type:
- Article
Clinical validation of the Lumipulse G β‐amyloid ratio (1‐42/1‐40) in a subset of ADNI CSF samples.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055657
- By:
- Publication type:
- Article
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 9, p. 1575, doi. 10.1002/alz.12316
- By:
- Publication type:
- Article
AD biomarker stability for stored CSF based on immunoassay results: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040747
- By:
- Publication type:
- Article
First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1493, doi. 10.1002/alz.12145
- By:
- Publication type:
- Article
Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 1, p. 144, doi. 10.1002/alz.12000
- By:
- Publication type:
- Article
P4‐705: TOWARD RE‐CALIBRATION OF COMMERCIAL IMMUNOASSAYS USING CERTIFIED REFERENCE MATERIALS FOR Aβ<sub>42</sub> IN HUMAN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1602, doi. 10.1016/j.jalz.2019.09.069
- By:
- Publication type:
- Article
P4‐552: LUMIPULSE G® CSF AD BIOMARKER CONCORDANCE TO PET IN THE KBASE COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1529, doi. 10.1016/j.jalz.2019.08.099
- By:
- Publication type:
- Article
P1‐266: COMPARISON OF A FULLY AUTOMATED BEAD‐BASED SYSTEM WITH AN ENZYME‐LINKED IMMUNOSORBENT ASSAY AND AN ELECTROCHEMILUMINESCENT ASSAY FOR MEASUREMENT OF CORE AD BIOMARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P341, doi. 10.1016/j.jalz.2019.06.821
- By:
- Publication type:
- Article
Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 1, p. 55, doi. 10.1016/j.jalz.2018.08.006
- By:
- Publication type:
- Article
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 10, p. 1313, doi. 10.1016/j.jalz.2018.05.008
- By:
- Publication type:
- Article
P4‐075: LUMIPULSE<sup>®</sup> G TOTAL TAU TO β‐AMYLOID 1‐42 RATIO CUT‐POINT DETERMINATION FOR AMYLOID ELIGIBILITY SCREENING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1463, doi. 10.1016/j.jalz.2018.06.2478
- By:
- Publication type:
- Article
P1‐276: ANALYTICAL PERFORMANCE OF A FULLY AUTOMATED CHEMILUMINESCENT β‐AMYLOID 1‐40 ASSAY ON THE LUMIPULSE G SERIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P388, doi. 10.1016/j.jalz.2018.06.282
- By:
- Publication type:
- Article
P1‐290: CONCORDANCE BETWEEN IN VIVO AMYLOID IMAGING AND CSF AB<sub>1‐42</sub> AND TOTAL TAU MEASURED BY THE AUTOMATED LUMIPULSE<sup>®</sup> G ASSAY PLATFORM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P396, doi. 10.1016/j.jalz.2018.06.296
- By:
- Publication type:
- Article
P1‐282: ANALYTICAL PERFORMANCE OF A FULLY AUTOMATED CHEMILUMINESCENT PTAU 181 ASSAY ON THE LUMIPULSE G SERIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P391, doi. 10.1016/j.jalz.2018.06.288
- By:
- Publication type:
- Article
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 7, p. 1177, doi. 10.1515/cclm-2015-0733
- By:
- Publication type:
- Article
VALIDATION OF CSF TUBES FOR USE ON THE LUMIPULSE® G PLATFORM: IMPACT ON Aβ1-42.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P200, doi. 10.1016/j.jalz.2017.07.063
- By:
- Publication type:
- Article
LUMIPULSE® G TOTAL TAU: KEY PERFORMANCES OF A FULLY AUTOMATED CHEMILUMINESCENT IMMUNOASSAY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1512, doi. 10.1016/j.jalz.2017.07.628
- By:
- Publication type:
- Article
COMMUTABILITY OF THE CANDIDATE CERTIFIED REFERENCE MATERIALS FOR THE STANDARDIZATION OF Aβ1-42 MEASUREMENTS IN HUMAN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1153, doi. 10.1016/j.jalz.2016.07.056
- By:
- Publication type:
- Article
PERFORMANCE OVERVIEW OF THE INNOTEST B-AMYLOID(1-40).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P663, doi. 10.1016/j.jalz.2016.06.1504
- By:
- Publication type:
- Article
USE OF CSF AB1-42 AND AB1-40 IN THE CLINICAL TYPING OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P474, doi. 10.1016/j.jalz.2016.06.931
- By:
- Publication type:
- Article
VERIFICATION OF THE ANALYTICAL PERFORMANCE OF THE FULLY AUTOMATED LUMIPULSE G β-AMYLOID 1-42 AND LUMIPULSE G TOTAL TAU ASSAYS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P483, doi. 10.1016/j.jalz.2016.06.951
- By:
- Publication type:
- Article
Correlation of the modified innotest β-amyloid 1-42 with a lc-ms/ms candidate reference method.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P385, doi. 10.1016/j.jalz.2015.06.314
- By:
- Publication type:
- Article
Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 5, p. S290, doi. 10.1016/j.jalz.2013.10.004
- By:
- Publication type:
- Article
Improvements to innotest® phospho-tau 181P.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P796, doi. 10.1016/j.jalz.2014.05.1551
- By:
- Publication type:
- Article
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 1, p. 53, doi. 10.1016/j.jalz.2012.12.006
- By:
- Publication type:
- Article
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 2, p. 137, doi. 10.1016/j.jalz.2012.11.003
- By:
- Publication type:
- Article
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 9, p. 1029, doi. 10.1001/jamaneurol.2015.1285
- By:
- Publication type:
- Article
Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 4, p. 710, doi. 10.1373/clinchem.2012.201830
- By:
- Publication type:
- Article
Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE<sup>®</sup> system.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 12, p. 1898, doi. 10.1002/acn3.51681
- By:
- Publication type:
- Article
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01116-2
- By:
- Publication type:
- Article
Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans: CSF AD biomarkers measured by Lumipulse in Koreans.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-020-00767-3
- By:
- Publication type:
- Article
Transient increase in CSF GAP-43 concentration after ischemic stroke.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 2, p. 207, doi. 10.1515/cclm-2021-0651
- By:
- Publication type:
- Article
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 12, p. 2058, doi. 10.1515/cclm-2018-0147
- By:
- Publication type:
- Article